Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2,007 DKK | -2.48% | -3.79% | -6.87% |
Apr. 16 | Genmab, Johnson & Johnson Logs Higher Q1 Sales for Blood Cancer Drug | MT |
Apr. 16 | Genmab A/S Announces DARZALEX Sales Results for the First Quarter of 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.87% | 18.6B | |
-3.39% | 102B | |
+2.61% | 96.84B | |
-1.02% | 21.48B | |
-18.14% | 20.82B | |
-40.70% | 16.81B | |
-26.89% | 13.78B | |
+1.12% | 13.4B | |
+22.25% | 11.06B | |
-18.85% | 8.88B |
- Stock Market
- Equities
- GMAB Stock
- News Genmab A/S
- Genmab A/S : HC Wainwright Adjusts Genmab's Price Target to $44 From $45, Keeps at Buy